An Italian biopharmaceutical company
The company is focused on the discovery, development and commercialization of monoclonal antibodies
Product pipeline
Products based on monoclonal antibodies
MediaPharma is committed to developing innovative products based on monoclonal antibodies designed to safely and effectively treat patients with cancer and improve patient outcomes.
|
Product |
Description |
Product Type |
Status |
|
MP-RM-1 |
Mouse antibody |
Preclinical |
|
|
MP-AA-1 |
Mouse antibody |
Preclinical |
|
|
MP-PN-1 |
Mouse antibody |
Preclinical |
|
|
MP-PN-2 |
Mouse antibody |
Research |
Last updated: 13/12/2010 11:11
MediaPharma s.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532
The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.
